|1.||Shoenfeld, Yehuda: 8 articles (07/2013 - 02/2002)|
|2.||Fritzler, Marvin J: 7 articles (12/2015 - 11/2007)|
|3.||Putterman, Chaim: 7 articles (09/2015 - 02/2004)|
|4.||Ramos-Casals, Manuel: 7 articles (04/2010 - 04/2002)|
|5.||Martini, Alberto: 6 articles (02/2015 - 08/2003)|
|6.||Ravelli, Angelo: 6 articles (07/2014 - 08/2003)|
|7.||Bossuyt, Xavier: 6 articles (04/2014 - 07/2003)|
|8.||Hansson-Hamlin, Helene: 5 articles (12/2015 - 12/2006)|
|9.||Mahler, Michael: 5 articles (12/2015 - 01/2012)|
|10.||Perl, Andras: 5 articles (10/2015 - 01/2005)|
|1.||Systemic Lupus Erythematosus (Libman-Sacks Disease)
07/01/2007 - "Immunofluorescence microscopy is superior to fluorescent beads for detection of antinuclear antibody reactivity in systemic lupus erythematosus patients."
09/01/2004 - "To study associations between antinuclear antibodies (ANA) and signs/symptoms in patients with systemic lupus erythematosus (SLE). "
01/01/2002 - "Several excellent animal models for systemic lupus erythematosus are available to study the pathogenetic mechanisms of anti-DNA antibodies, immunological mechanisms for their origin and the influence of susceptibility genes for the development of anti-DNA antibodies. "
08/25/2001 - "The aim of this study is to prepare magnetic poly(2-hydroxyethylmethacrylate) (mPHEMA) beads and to investigate their utility for the removal of anti-DNA antibodies from systemic lupus erythematosus (SLE) patient plasma. "
02/01/1996 - "The ELISA procedure established in this study is showed to be a available method to detect anti-DNA antibodies associated with renal disease in patients with systemic lupus erythematosus."
05/01/1978 - "Such treated mice had reduced anti-DNA antibodies, reduced proteinuria, and improved survival. "
05/01/1986 - "Similar to our past studies, this treatment resulted in a marked prolongation of survival, decrease in proteinuria, and decrease in serum anti-DNA antibodies compared with untreated littermate controls. "
11/01/2015 - "SMAs 11a and 12b were evaluated for their ability to suppress antinuclear antibody (ANA) generation and consequent kidney pathology in MRL/Lpr mice when administered after the onset of proteinuria. "
04/01/2015 - "The parasitic worm product ES-62 targets myeloid differentiation factor 88-dependent effector mechanisms to suppress antinuclear antibody production and proteinuria in MRL/lpr mice."
10/01/2014 - "Disease was monitored by antinuclear antibody (ANA) production, proteinuria, and renal histology. "
01/01/1991 - "This study presents 8 dogs of German Shepherd breed (6 males, 2 females, 2-5 years of age at onset of the disease) with a lupus like syndrome characterized by febrile polyarthritis, wasting, nephropathy, cutaneous lesions and high positive titres of ANA (antinuclear antibodies) of speckled type. "
09/01/2015 - "Common clinical features in ILE include antinuclear antibody seropositivity, polyarthritis, immunologic manifestations, and hematological disorders. "
11/01/2014 - "In contrast, the allele FCGR2A-H-131 was associated with susceptibility to arthritis and anti-DNA antibodies (p = 0.05 for both). "
09/01/2014 - "These patients were also distinctive as being significantly older, more likely to be male, and less likely to have positive antinuclear antibody titers than other patients with ankle/hindfoot/midfoot complex arthritis. "
07/01/2014 - "Risk factors included sex, age at arthritis onset, disease category, and antinuclear antibody (ANA) status. "
|4.||Rheumatic Diseases (Rheumatism)
01/01/2013 - "Indirect immunofluorescence (IIF) is the gold standard method for the detection of antinuclear antibodies (ANA) which are essential markers for the diagnosis of systemic autoimmune rheumatic diseases. "
05/01/2000 - "The facilities to detect antinuclear antibodies (ANA) patterns in patients with systemic rheumatic diseases/connective tissue disorders (CTD) using indirect immunofluorescence (IIF) technique (the gold standard) are sparse; the technique is technically difficult and expensive. "
03/01/2015 - "The study was organized to comparatively analyze automated and visual interpretation of results of IRIF HEp-2 in detection of content antinuclear antibodies in patients with rheumatic diseases. "
01/01/2008 - "The aim of this study was to investigate the types and prevalence of disease-specific antinuclear antibodies (ANAs) and their relationship to rheumatic diseases in the general Japanese population. "
11/01/2015 - "For the serological diagnosis of systemic autoimmune rheumatic diseases, a two-tier approach starting with sensitive antinuclear antibody (ANA) detection by indirect immunofluorescence (IIF) on HEp-2 cells followed by characterization of positive findings with different immunoassays is recommended. "
03/01/1977 - "Skin immunofluorescence studies are helpful in differential diagnosis when patients with a clinical picture of rheumatoid arthritis present with serum antinuclear antibodies and lupus erythematosus cells. "
07/01/1982 - "Studies of antinuclear antibodies in rheumatoid arthritis."
06/01/2015 - "Systemic examinations revealed hyperglobulinemia, increased blood viscosity, increased antinuclear antibody, increased rheumatoid arthritis particle aggregation, and increased anti-SS-A antibody. "
01/01/2005 - "[immunological and serological tests for diagnosis of rheumatoid arthritis: antinuclear antibodies]."
07/01/1998 - "Examinations of 121 patients with rheumatoid arthritis (RA) included immunological testing for antinuclear antibodies (ANA), lymphocyte blastogenesis test, and leukocyte migration inhibition test and functional cardiological examinations (ECG and EchoCG). "
|1.||DNA (Deoxyribonucleic Acid)
|4.||Antigen-Antibody Complex (Immune Complex)
|5.||Complement System Proteins (Complement)
|5.||Breast Implants (Breast Implant)